Ipamorelin’s Efficacy in Reducing Sleep Apnea Severity: A 3-Year Study in American Males
Reading Time: 3 minutes Introduction Sleep apnea, a common yet serious sleep disorder, predominantly affects men and can lead to significant health issues if left untreated. Recent research has explored various therapeutic interventions, with a particular focus on pharmacological agents that might improve sleep quality and reduce apnea episodes. One such agent, Ipamorelin, a growth hormone-releasing peptide, has been the subject of a comprehensive three-year study involving over 200 American males. This article delves into the findings of this study, assessing the efficacy of Ipamorelin in managing sleep apnea. Study Design and Methodology The study was designed as a randomized, double-blind, placebo-controlled trial to...


